CompletedEUCTR 2019-001989-15
This study is comparing fremanezumab with placebo for people with Migraine and depression or Elderly. Participants receive fremanezumab or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany, Czech Republic, France, Finland, Greece, Spain, Italy, View results
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Depression
OngoingEUCTR 2015-003042-47
This study is looking at whether Deroxat® can help people with Generalised anxiety or Elderly. Participants receive the study medicine Deroxat® and complete study visits and assessments.
AnxietyOther
- Countries
- France
- Sponsor
- Centre Hospitalier Henri Laborit
- Condition
- Anxiety
OngoingEUCTR 2009-018277-31
This observational study is following people with Thyroidectomie pour carcinome papillaire différencié or Elderly to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
Mental healthOther
- Countries
- France
- Sponsor
- CHU de Nîmes
- Condition
- Mental health
OngoingEUCTR 2007-007538-21
This study is looking at care and outcomes for people with Diagnosis of Schizophrenia in Male or female, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised and confirmed by the St. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOther
- Countries
- France
- Sponsor
- CYRENAIC
- Condition
- Schizophrenia
OngoingEUCTR 2010-018416-33
This study is looking at whether FENOFIBRATE MYLAN 200 mg, gélule can help people with schizophrénia or Elderly. Participants receive the study medicine FENOFIBRATE MYLAN 200 mg, gélule and complete study visits and assessments.
SchizophreniaOther
- Countries
- France
- Sponsor
- Centre Hospitalier Régional et Universitaire de Lille
- Condition
- Schizophrenia
CompletedEUCTR 2017-001447-12
This study is comparing Brexpiprazole with placebo for people with Schizophrenia or Adolescents, Under 18. Participants receive Brexpiprazole or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Hungary, Spain, Poland, Bulgaria, France, Italy, Romania, View results
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
OngoingEUCTR 2020-003745-11
This study is looking at whether None yet can help people with Schizophrenia. Participants receive the study medicine None yet and complete study visits and assessments.
SchizophreniaOther
- Countries
- France, Czech Republic, Spain, Slovakia, Hungary, Norway, Denmark, Lithuania, Italy, Greece, Belgium, Sweden, Netherlands, Finland, Croatia, Austria, Bulgaria, Portugal, Romania
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
OngoingEUCTR 2022-001515-10
This study is comparing Trospium chloride with placebo for people with Psychosis Associated with Alzheimer’s Disease Dementia or Elderly. Participants receive Trospium chloride or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain, Slovakia, France, Italy, Bulgaria, Germany
- Sponsor
- Karuna Therapeutics
- Condition
- Schizophrenia
OngoingEUCTR 2017-002227-13
This study is comparing Pimavanserin with placebo for people with Hallucinations and Delusions Associated With Dementia-related Psychosis or Elderly. Participants receive Pimavanserin or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- United Kingdom, Czech Republic, Slovakia, Bulgaria, Spain, Poland, France, Italy, View results
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT04133233
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Condition
- Depression
Not Yet RecruitingNCT07503275
This study exists to see whether the medication Inhibitory can play a useful role in care. Researchers are trying to understand whether the medication Inhibitory can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- CHU de Reims
- Condition
- Depression
CompletedNCT02794129
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- CHU de Reims
- Condition
- Bipolarity
CompletedNCT01312649
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
CompletedNCT05922956
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Condition
- Bipolarity
CompletedNCT06809881
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Condition
- Bipolarity
TerminatedNCT02765880
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
CompletedNCT04436757
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Depression
CompletedNCT05650788
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 40 Years
- Countries
- France
- Sponsor
- University Hospital, Clermont-Ferrand
- Condition
- Bipolarity
CompletedNCT05603819
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 80 Years
- Countries
- Denmark, France, Spain
- Sponsor
- Alcediag
- Condition
- Bipolarity
CompletedNCT06661616
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier St Anne
- Condition
- Depression
TerminatedNCT05161546
This study exists to compare options and see whether the medication Bipolar offers something meaningfully different. Researchers are trying to understand whether the medication Bipolar can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
- Condition
- Bipolarity
CompletedNCT04590300
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Charles Perrens, Bordeaux
- Condition
- Schizophrenia
TerminatedNCT03508427
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Institut Pasteur
- Condition
- Bipolarity
CompletedNCT05965232
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
BipolarityOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Esquirol
- Condition
- Bipolarity
CompletedNCT01644747
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Condition
- Depression